A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-26
DOI
10.1038/s41379-019-0302-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary
- (2018) Chen Yang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- SATB2 is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract
- (2018) Changqing Ma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials
- (2018) Nicola S. Meagher et al. GYNECOLOGIC ONCOLOGY
- Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
- (2018) Linyuan Wang et al. HISTOPATHOLOGY
- Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas
- (2017) Ankur R. Sangoi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications
- (2017) Peter Rambau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- (2017) et al. JAMA Oncology
- SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
- (2016) Michelle Moh et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours
- (2016) Sarah Strickland et al. HISTOPATHOLOGY
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Differing expression profiles ofNotch/enterocyte andWnt/secretory lineage signallings are associated with morphological diversity of appendiceal tumours
- (2016) Xianyong Gui et al. JOURNAL OF CLINICAL PATHOLOGY
- PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature
- (2016) D. Ates Ozdemir et al. PATHOLOGY & ONCOLOGY RESEARCH
- A Series of Malignant Ovarian Cancers Arising From Within a Mature Cystic Teratoma
- (2015) Jonathan D. Black et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
- (2015) Georgina L. Ryland et al. Genome Medicine
- Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
- (2014) M Köbel et al. BRITISH JOURNAL OF CANCER
- BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression
- (2014) Michael S. Landau et al. HUMAN PATHOLOGY
- Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
- (2013) G Nishikawa et al. BRITISH JOURNAL OF CANCER
- An Evaluation of the Morphologic Features of Low-grade Mucinous Neoplasms of the Appendix Metastatic in the Ovary, and Comparison With Primary Ovarian Mucinous Tumors
- (2013) Colin J.R. Stewart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
- (2012) J Eberhard et al. BRITISH JOURNAL OF CANCER
- SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas
- (2011) Kristina Magnusson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1
- (2011) W Glenn McCluggage JOURNAL OF CLINICAL PATHOLOGY
- Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
- (2011) Linda E Kelemen et al. LANCET ONCOLOGY
- PAX 8 expression in non-neoplastic tissues, primary tumors and metastatic tumors: a comprehensive immunohistochemical study
- (2011) Ayhan Ozcan et al. MODERN PATHOLOGY
- Expression of PAX8 in Normal and Neoplastic Tissues
- (2011) David Tacha et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal
- (2010) Richard J. Zaino et al. CANCER
- Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
- (2010) Ali Dastranj Tabrizi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started